Zhao-Hui Huang1, Li-Hua Li, Fan Yang, Jin-Fu Wang. 1. Oncology Institute of Wuxi, The Fourth Affiliated Hospital of Soochow University, 200 Huihe Road, Wuxi 214062, Jiangsu Province, China. hzhwxsy@yahoo.com.cn
Abstract
AIM: To investigate the feasibility of detecting methylated fecal DNA as a screening tool for colorectal carcinoma (CRC) and precancerous lesions. METHODS: Methylated secreted frizzled-related protein gene 2 (SFRP2), hyperplastic polyposis protein gene (HPP1) and O6-methylguanine-DNA methyltransferase gene (MGMT) in stools from 52 patients with CRC, 35 patients with benign colorectal diseases and 24 normal individuals were analyzed using methylation-specific PCR. RESULTS: Methylated SFRP2, HPP1 and MGMT were detected in 94.2%, 71.2%, 48.1% of CRC patients and 52.4%, 57.1%, 28.6% of adenoma patients, respectively. The overall prevalence of fecal DNA with at least one methylated gene was 96.2% and 81.8% in patients with CRC and precancerous lesions, respectively. In contrast, only one of the 24 normal individuals revealed methylated DNA. These results indicated a 93.7% sensitivity and a 77.1% specificity of the assay for detecting CRC and precancerous lesions. CONCLUSION: Methylation testing of fecal DNA using a panel of epigenetic markers may be a simple and promising non-invasive screening method for CRC and precancerous lesions.
AIM: To investigate the feasibility of detecting methylated fecal DNA as a screening tool for colorectal carcinoma (CRC) and precancerous lesions. METHODS: Methylated secreted frizzled-related protein gene 2 (SFRP2), hyperplastic polyposis protein gene (HPP1) and O6-methylguanine-DNA methyltransferase gene (MGMT) in stools from 52 patients with CRC, 35 patients with benign colorectal diseases and 24 normal individuals were analyzed using methylation-specific PCR. RESULTS: Methylated SFRP2, HPP1 and MGMT were detected in 94.2%, 71.2%, 48.1% of CRCpatients and 52.4%, 57.1%, 28.6% of adenomapatients, respectively. The overall prevalence of fecal DNA with at least one methylated gene was 96.2% and 81.8% in patients with CRC and precancerous lesions, respectively. In contrast, only one of the 24 normal individuals revealed methylated DNA. These results indicated a 93.7% sensitivity and a 77.1% specificity of the assay for detecting CRC and precancerous lesions. CONCLUSION: Methylation testing of fecal DNA using a panel of epigenetic markers may be a simple and promising non-invasive screening method for CRC and precancerous lesions.
Authors: Fumiaki Sato; David Shibata; Noam Harpaz; Yan Xu; Jing Yin; Yuriko Mori; Suna Wang; Andreea Olaru; Elena Deacu; Florin M Selaru; Martha C Kimos; Prodromos Hytiroglou; Joanne Young; Barbara Leggett; Adi F Gazdar; Shinichi Toyooka; John M Abraham; Stephen J Meltzer Journal: Cancer Res Date: 2002-12-01 Impact factor: 12.701
Authors: Hannes M Müller; Michael Oberwalder; Heidi Fiegl; Maria Morandell; Georg Goebel; Matthias Zitt; Markus Mühlthaler; Dietmar Ofner; Raimund Margreiter; Martin Widschwendter Journal: Lancet Date: 2004-04-17 Impact factor: 79.321
Authors: Wai K Leung; Ka-Fai To; Ellen P S Man; Michael W Y Chan; Alfa H C Bai; Aric J Hui; Francis K L Chan; Janet F Y Lee; Joseph J Y Sung Journal: Clin Chem Date: 2004-11 Impact factor: 8.327
Authors: Nigel J Belshaw; Giles O Elliott; Elizabeth A Williams; David M Bradburn; Sarah J Mills; John C Mathers; Ian T Johnson Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-09 Impact factor: 4.254
Authors: Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Carol Smigal; Michael J Thun Journal: CA Cancer J Clin Date: 2006 Mar-Apr Impact factor: 508.702
Authors: Hiromu Suzuki; D Neil Watkins; Kam-Wing Jair; Kornel E Schuebel; Sanford D Markowitz; Wei Dong Chen; Theresa P Pretlow; Bin Yang; Yoshimitsu Akiyama; Manon Van Engeland; Minoru Toyota; Takashi Tokino; Yuji Hinoda; Kohzoh Imai; James G Herman; Stephen B Baylin Journal: Nat Genet Date: 2004-03-14 Impact factor: 38.330
Authors: J Young; K G Biden; L A Simms; P Huggard; R Karamatic; H J Eyre; G R Sutherland; N Herath; M Barker; G J Anderson; D R Fitzpatrick; G A Ramm; J R Jass; B A Leggett Journal: Proc Natl Acad Sci U S A Date: 2001-01-02 Impact factor: 11.205
Authors: Barbara Kinga Barták; Alexandra Kalmár; Bálint Péterfia; Árpád V Patai; Orsolya Galamb; Gábor Valcz; Sándor Spisák; Barnabás Wichmann; Zsófia Brigitta Nagy; Kinga Tóth; Zsolt Tulassay; Péter Igaz; Béla Molnár Journal: Epigenetics Date: 2017-09-26 Impact factor: 4.528